Metabolite profiles and the risk of diabetes in Asians
Project Number7R01DK108159-06
Former Number5R01DK108159-05
Contact PI/Project LeaderWANG, THOMAS J. Other PIs
Awardee OrganizationUT SOUTHWESTERN MEDICAL CENTER
Description
Abstract Text
DESCRIPTION (provided by applicant): Type 2 diabetes mellitus (DM) is a major source of
morbidity and mortality worldwide. Cases of DM are expected to rise by 72% through 2025,
affecting 325 million people across all nations and income groups. It is increasingly recognized
that there is phenotypic heterogeneity among individuals who develop DM. One subgroup that
has attracted particular attention in recent years is the "lean diabetes" group, e.g. individuals with
DM in the absence of obesity. Lean individuals with DM are at substantially higher risk of
mortality and other complications than obese individuals with DM. However, little is known
about the factors that promote DM in the absence of obesity, or the mechanisms underlying the
worse outcomes in this subset. Asians are particularly susceptible to developing lean DM.
Approximately half of Asians who develop DM are considered normal weight (BMI less than 25
kg/m2). This propensity is independent of country of residence, e.g. it affects Asians living in th
U.S. as well as in Asian countries. Indeed, studies in the U.S. indicate very high rates of DM
among Asian-Americans. The pathogenesis of DM reflects a complex interplay of genetic,
dietary, and environmental exposures affecting multiple pathways. One approach to
understanding the activity in many metabolic pathways at once is metabolomics profiling.
"Metabolomics" refers to the systematic analysis of metabolites in a biological specimen, such as
plasma. Combining biomarker and phenotypic data in human populations provides a rich
opportunity to identify the biochemical signatures of metabolic diseases, which can enhance
biological understanding as well as yield tools for disease screening. Metabolomics data from
non-European cohorts, and particularly Asian cohorts, are sparse. The differences in the
epidemiology of DM across racial/ethnic groups suggest the possibility of pathophysiological
differences. Recently, in a preliminary study in the Shanghai Women's Health Study (SWHS),
we found evidence that Chinese women had some risk markers for DM that were distinct from
those described in European populations. Thus, we propose to expand considerably on our work
in European populations and our pilot studies in the SWHS, by performing comprehensive
metabolomics profiling in 2 Chinese cohorts to identify metabolites that are associated with
incident DM. Our aims are (1) to identify metabolites that associate with incident DM in Chinese
individuals enrolled in the SWHS and Shanghai Men's Health Study (SMHS); and (2) to
replicate the association of metabolites with incident DM in a separate case-cohort study.
Public Health Relevance Statement
Contact PD/PI: Wang, Thomas J
NARRATIVE
The majority of diabetes cases worldwide in the next decade are expected to occur among Asian individuals,
and Asians in this country have high rates of developing diabetes as well. Studying why Asians, particularly
lean Asians, are particularly susceptible to diabetes should enhance our biological understanding of the
disease, and facilitate the development of strategies for prevention and treatment.
Project Narrative Page 7
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
800771545
UEI
YZJ6DKPM4W63
Project Start Date
10-February-2021
Project End Date
31-March-2023
Budget Start Date
10-February-2021
Budget End Date
31-March-2023
Project Funding Information for 2019
Total Funding
$191,052
Direct Costs
$103,280
Indirect Costs
$87,772
Year
Funding IC
FY Total Cost by IC
2019
National Institute of Diabetes and Digestive and Kidney Diseases
$191,052
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R01DK108159-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01DK108159-06
Patents
No Patents information available for 7R01DK108159-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01DK108159-06
Clinical Studies
No Clinical Studies information available for 7R01DK108159-06
News and More
Related News Releases
No news release information available for 7R01DK108159-06
History
No Historical information available for 7R01DK108159-06
Similar Projects
No Similar Projects information available for 7R01DK108159-06